EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of First-in-Class Inhibitors Targeting a Pathogen-Associated Aminoglycoside-Resistance 16S rRNA Methyltransferase

Debayan Dey iD, Benjamin E Deprez, Natalia Zelinskaya iD, Jose M Castro iD, William M Wuest iD, Graeme L Conn iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Debayan Dey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322, United States. Hauptthemen laut MEDLINE: Methyltransferases, Aminoglycosides, Drug Resistance, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesAminoglycosidesDrug Resistance, BacterialAnti-Bacterial AgentsRNA, Ribosomal, 16SEnzyme InhibitorsDrug DiscoveryBinding SitesMolecular Dynamics SimulationEscherichia coli ProteinsEscherichia coli

Stichwörter der Autor:innen

antibiotic resistancechemoinformaticshigh-throughput virtual screeningmethyltransferaseprecision dockingrRNA

Substanzen

MethyltransferasesAminoglycosidesAnti-Bacterial AgentsRNA, Ribosomal, 16SEnzyme InhibitorsEscherichia coli ProteinsNpmA protein, E coli

Autor:innen und Institutionen

  • Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
  • Department of Chemistry, Emory University, Atlanta, Georgia 30322, United States.
  • Graduate Program in Biochemistry, Cell and Developmental Biology (BCDB), Emory University, Atlanta, Georgia 30322, United States.

ORCID-Profile: Debayan Dey, Natalia Zelinskaya, Jose M Castro, William M Wuest, Graeme L Conn

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • Medicinal Chemistry Division, American Chemical Society
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Dey, D., Deprez, B. E., Zelinskaya, N., Castro, J. M., Wuest, W. M., & Conn, G. L. (2025). Discovery of First-in-Class Inhibitors Targeting a Pathogen-Associated Aminoglycoside-Resistance 16S rRNA Methyltransferase. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00297

Vancouver

Dey D, Deprez BE, Zelinskaya N, Castro JM, Wuest WM, Conn GL. Discovery of First-in-Class Inhibitors Targeting a Pathogen-Associated Aminoglycoside-Resistance 16S rRNA Methyltransferase. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00297

BibTeX
@article{Dey2025,
  author = {Dey, Debayan and Deprez, Benjamin E and Zelinskaya, Natalia and Castro, Jose M and Wuest, William M and Conn, Graeme L},
  title = {Discovery of First-in-Class Inhibitors Targeting a Pathogen-Associated Aminoglycoside-Resistance 16S rRNA Methyltransferase},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00297}
}
Kostenlos starten →